Weimin Ke

Titles

Professor & Chief Physician

Infectious Diseases Department

Research Interests

Liver failure with hepatitis B

Infections of central nerve system

Education and Experience

1978-1983 Medical Student, Medical Science Department, the Sun Yat-sen University

1985-1988 Graduate Student, Sun Yat-sen Medical University

1993-1994 Trainer, Nishinomiya Hospital, Hyogo, Japan

1983-1990 Residency

1990-1995 Lecturer

1995-2004 Associate Professor

2004-present Professor and Chief Physician

Honors and Awards

1996 &1998 Medical Awards of Sun Yat-sen Medical University

1999 Medical Award of Health Department of Guangdong Province

2009 Award of Science and Technology of Guangdong Province

2015 Award of Chinese Medical Association

Publications

1.Wei-Min Ke, De Tan, Jian-Guo Li, Satoru Izumi, Yoshitake Shinji, Hak Hotta, and Ji-Lu Yao. Consecutive evaluation of immunoglobulin M and G antibodies against Hepatitis E Virus. J Gastroenterol, 1996, 31(6):818－822.

2.Wei-Min Ke, Yi-Nong Ye, Shi Huang. Discriminant function for prognosis indexes and probability of death in chronic severe hepatitis B. J Gastroenterol, 2003,38(9): 861～864。

3.i-Min Ke, Xue-Jun Li, Jing Lai, Xiao-He Li, Zhi-Liang Gao, Pei-Jia Chen. Etiological investigation of fatal liver failure during the course of chronic hepatitis B in southeast China. J Gastroenterol, 2006, 41(4): 347－351.

4.i-Min Ke, Shi-Bin Xie, Li-Na Yu, Ting Liu, Jing Lai, Da-Qiu He, Xiao-He Li, Zhi-Liang Gao, Ying Ke and Pei-Jia, Chen. Decline of Serum HBV DNA and no Change Apportioned by the Same Hepatic Parenchyma Cell Volume from Hepatic Fibrosis Stage 1 to Stage 4 during the Natural History of Chronic Hepatitis B. Intervirology, 2008, 51(4): 235－240.

5.aohong Zhang, Weimin Ke, Junqiang Xie, Zhixin Zhao, Dongying Xie, Zhiliang Gao. Comparison of effects of hepatitis E or A viral superinfection in patients with chronic hepatitis B. Hepatol Int. 2010,4:615-620.

6.i-Bin Xie, Chao Ma, Chao-Shuang Lin, Ying Zhang, Jian-Yun Zhu and Wei-Min Ke. Collagen proportionate area of liver tissue determined by digital image analysis in patients with HBV-related decompensated cirrhosis. Hepatobiliary Pancreat Dis Int, 2011, 5(10): 497-501.

7.-M. Ke, S.-B. Xie, X.-J. Li, S.-Q. Zhang, J. Lai, Y.-N. Ye, Z.-L. Gao, P.-J. Chen.There were no differences in serum HBV DNA level between HBeAg-positive and HBeAg-negative chronic hepatitis B with same liver histological necroinflammation grade but differences among grades 1, 2, 3 and 4 apportioned by the same hepatic parenchyma cell volume. Journal of Viral Hepatitis. 2011,18 (9): 637– 645.  

8.eng YB, Xie DY, Gu YR, Yan Y, Wu YB, Lei ZY, Peng L, Xie SB, Gao ZL, Ke WM. Development of a sensitive prognostic scoring system for the evaluation of severity of acute-on-chronic hepatitis B liver failure: a retrospective cohort study.Clin Invest Med. 2012 ;35(2):E75-85.

9.n Y, Mai L, Zheng YB, Zhang SQ, Xu WX, Gao ZL, Ke WM. What MELD score mandates use of entecavir for ACLF-HBV HBeAg-negative patients? World J Gastroenterol. 2012 ;18(33):4604-4609.

10. J, Yan Y, Mai L, Zheng YB, Gan WQ, Ke WM. Short-term entecavir versus lamivudine therapy for HBeAg-negative patients with acute-on-chronic hepatitis B liver failure. Hepatobiliary Pancreat Dis Int. 2013 ;12(2):154-159.

(Total Publications 114: 75 Papers of First Author and Corresponding Author, 9 Medical Books and 2 Medical Text Books)

Contact

The Third Affiliated Hospital of Sun Yat-sen University

600 Tianhe Rd, Guangzhou, China, 510630

Email: Kwm1999@163.com